Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 59 Squamous Cell Carcinoma of Head and Neck 38 Nasopharyngeal Carcinoma 27 Lung Neoplasms 26 Biliary Tract Neoplasms 24 Uterine Cervical Neoplasms 23 Esophageal Squamous Cell Carcinoma 20 Oropharyngeal Neoplasms 19 Cholangiocarcinoma 18 Head and Neck Neoplasms 17 Urinary Bladder Neoplasms 14 Ovarian Neoplasms 14 Neoplasms 14 Neoplasm Metastasis 13 Esophageal Neoplasms 13 Colorectal Neoplasms 12 Carcinoma 12 Stomach Neoplasms 10 Small Cell Lung Carcinoma 9 Carcinoma, Squamous Cell 9 Mouth Neoplasms 8 Carcinoma, Transitional Cell 8 Laryngeal Neoplasms 7 Hypopharyngeal Neoplasms 7 Recurrence 6 Pancreatic Neoplasms 6 Nasopharyngeal Neoplasms 5 Gallbladder Neoplasms 5 Endometrial Neoplasms 5 Breast Neoplasms 5

Interventions

Taxes 1 Standard of Care 1 Radiotherapy 1 Nivolumab 1 Immunotherapy 1 Cisplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Muscle-Invasive Bladder Carcinoma × Cisplatin × Clear all

NCT05203913 2024-10-04

CNN-BC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Recruiting

Muscle-Invasive Bladder Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡